Article

THE ALLIANCE FOR HUMAN RESEARCH PROTECTION (AHRP) April 10, 2003 Letter to the Editor The New England Journal of Medicine View letter as finally published in NEJ Sir: The April 3, 2003 New England Journal of Medicine (NEJM) issue contained an array of articles largely in support of a disputed…

Letter Submitted to New England Journal of Medicine re ARDS Investigation

The April 3, 2003 New England Journal of Medicine (NEJM) issue contained an array of articles largely in support of a disputed multi-site, clinical trial sponsored by the National Heart, Lung, and Blood Institute (NHLBI), one of the National Institutes of Health (NIH), involving critically-ill, mentally incapacitated human beings with acute respiratory distress syndrome (ARDS) – who did not give their informed consent.

The accompanying editorial, "Controlling Research Trials," by Dr. J.M. Drazen, who serves on the NHLBI advisory committee that had approved the disputed trial, reveals much about the NIH attitude toward the rest of the world.

AHRP Comments: DHHS COI Guidance for Human Subject Protection

THE ALLIANCE FOR HUMAN RESEARCH PROTECTION (AHRP) 142 West End Ave. Suite 28P New York, NY 10023 April 4, 2003 Tommy Thompson, Secretary Department of Health and Human Services Dockets Management Branch (HFA–305), Docket Number 02N–0475, Food and Drug Administration, 5630 Fishers Lane, Room 1061 Rockville, MD 20852. Re: Docket…

FDA Warning Letter Re: Fatal Experiment: Hexamethonium Inhalation_Johns Hopkins

FDA Warning Letter Re: Fatal Experiment: Hexamethonium Inhalation_Johns Hopkins Tue, 22 Apr 2003 An FDA Warning Letter was sent to Dr. Alkis Togias of the Johns Hopkins University Asthma & Allergy Center (March 31, 2003). The letter lists specific federal safety requirements and their violation in the hexamethonium inhalation experiment…

Children are Humans: Don’t Sacrifice their Rights, Dignity & Welfare

We are writing about the Pediatric Research Equity Act of 2003 (S 650). We are in full agreement that children should have the same safeguards as adults; that medications used in children be thoroughly tested for safety, effectiveness and appropriate dose. However, S 650 does not do this. Instead, it requires that children be used to test all drugs as a condition of licensure by FDA – unless a waiver is obtained from the Secretary of the department of Health and Human Services under section 505B.

CNN: Drug Argument Embroils Psychiatrists, Pharma Companies

CNN: Drug Argument Embroils Psychiatrists, Pharma Companies Sun, 30 Mar 2003 The seeds of doubt have begun to taken root and the media is beginning to ask probing questions about the unholy alliance that created the big lie resulting in the indiscriminate diagnosing of mental disorders. Even perfectly normal children…

Class Action Lawsuit Filed Following Deaths at VA_Albany

Class Action Lawsuit Filed Following Deaths at VA_Albany Thu, 20 Mar 2003 A class action lawsuit has been filed on March 18, 2003 in U.S. District Court(NY), by attorney Alan Milstein, on behalf of “all persons who participated in human subject experiments” conducted by defendants, oncologist Dr. James Holland and…

Article

February 25, 2003 8:33 AM Trauma counseling retraumatizes_Repress Yourself_NYT “Repress Yourself” an article in Sunday’s New York Times magazine provides Congress with very good reasons for taking back public funds from the mental health trauma industry that it infused with cash after 9/11. A scientific study conducted in Israel found…